Literature DB >> 18855874

Burden and timing of premature atrial contractions after electrical cardioversion of persistent atrial fibrillation do not predict its recurrence.

Dritan Poçi1, Britt-Marie Abrahamsson, Lennart Bergfeldt, Nils Edvardsson.   

Abstract

BACKGROUND: The heart is susceptible to recurrence of atrial fibrillation (AF) during the period immediately following conversion to sinus rhythm (SR). It is less clear whether various onset or trigger mechanisms can predict AF recurrence after direct current (DC) cardioversion of persistent AF.
METHODS: In this study, 172 patients (117 men), mean age 69 +/- 11 y, and with persistent AF underwent elective electrical cardioversion. A detailed analysis was made of the heart rhythm and potential AF trigger mechanisms based on 5 min electrocardiogram (ECG) recordings after conversion.
RESULTS: Of 151 patients discharged in SR, 45 (30%) had a recurrence of AF within 1 wk. Premature atrial contractions (PACs) were the most common potential trigger, occurring on an average of 3/min. They were equally frequent in patients with and without immediate and early reinitiation of AF, and in patients with and without AF recurrence at the 1-wk follow-up visit. Other trigger mechanisms were too infrequent to allow conclusions.
CONCLUSION: Premature atrial contractions were the most common potential trigger mechanism occurring immediately after cardioversion in patients with persistent AF. However, they neither predicted immediate and/or early reinitiations, nor recurrences during the first wk after cardioversion. Copyright (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18855874      PMCID: PMC6653405          DOI: 10.1002/clc.20285

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  1 in total

1.  Sinus bradycardia and sinus pauses immediately after electrical cardioversion of persistent atrial fibrillation--what do they mean?

Authors:  Dritan Poçi; Britt-Marie Abrahamsson; Nils Edvardsson; Lennart Bergfeldt
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.